Menu

他泽司他一次能囤几盒?多少钱?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Tazerestat is a methyltransferase inhibitor used to treat certain cancers, primarily patients with epithelioid sarcoma and follicular lymphoma. This article will focus on three aspects: drug hoarding quantity, price and medication for special groups to help patients and their families better understand this drug.

How many boxes of tazetostat can be stocked at one time?

The stocking quantity needs to be determined based on the patient’s specific medication needs and doctor’s advice. The recommended dose of the drug is 800 mg twice daily, so patients need to calculate the amount of medication required based on the length of treatment.

Drug specifications and dosage

The standard specification of tazerestat is 200 mg/tablet, and each bottle usually contains 240 tablets. Based on the dosage of 4 tablets twice a day, one bottle of medicine can meet the dosage for about 30 days. Patients can rationally plan the quantity of medicines they stock up based on the treatment cycle and doctor’s recommendations.

Suggestions on stocking up on medicines

For patients undergoing long-term treatment, it is recommended to stock up on medicines for 2-3 months at a time to reduce the inconvenience of frequent medicine purchases. However, attention should be paid to the storage conditions of the medicine to avoid high temperature environment affecting the efficacy of the medicine.

Notes

When stocking up on medicines, you need to ensure that the medicines come from regular sources and avoid buying fake and shoddy products. At the same time, regular reexaminations are conducted to evaluate the treatment effect and the medication regimen is adjusted in a timely manner.

How much does tazerestat cost?

The price of tazerestat varies depending on specifications and manufacturers. The following is a price reference for several common versions.

Laos Lucius Version

The specification of Tazerestat produced by Laos Lucius is 200mg*56 tablets, with a reference price of about US$777 per box, which is suitable for short-term treatment or patients with limited budget.

Laos Big Bear Version

The Laos Big Bear Version of tazerestat is available in 200mg*80 tablets, priced at approximately US$1,480 per box. It is relatively cost-effective and suitable for mid-term treatment needs.

Export the original version of tazerestat to Hong Kong

The specification of exporting the original version of tazerestat to Hong Kong is 200mg*240 tablets. The price of a box is about US$7,213. It is suitable for patients who require long-term treatment and pursue the quality of the original drug.

Factors affecting price

Drug prices are affected by market supply and demand, exchange rate fluctuations, transportation costs and other factors. When purchasing, it is recommended to compare multiple channels and choose formal channels to ensure drug quality.

Tazerestat's use in special populations

Tazerestat should be used with extreme caution in specific populations, including pregnant women, lactating women, children and the elderly.

Pregnant and lactating women

Using tazerestat in pregnant women may cause fetal damage, and strict contraception is required until 6 months after stopping the drug. Breastfeeding women should avoid breastfeeding while taking the drug to prevent the drug from affecting the baby through milk.

Pediatric patients

Tazerestat can be used for adolescents aged 16 years and above, but the safety and effectiveness of children under 16 years of age have not yet been determined, and the risks and benefits need to be fully assessed before use.

Elderly patients

There is limited medication data for elderly patients, and the dosage needs to be adjusted according to individual conditions. People with liver and kidney dysfunction should use it under the guidance of a doctor to avoid adverse reactions caused by drug accumulation.

Drug monitoring

Special groups need to closely monitor adverse reactions during medication, such as secondary malignant tumors or hematological abnormalities, and communicate with doctors in a timely manner to adjust treatment plans.

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。